Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
Two U.S. luxury houses and the FTC are set to battle in court to reach a final decision that will change the market.
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
U.S. Federal Trade Commission Chair Lina Khan on Friday welcomed that companies are weighing antitrust considerations early ...
It’s been almost a month since the new FTC rule was officially approved, but if you still can’t smell what The Rock-a-Khan is ...
At this week’s National Advertising Division Annual Conference, FTC Commissioner Melissa Holyoak and FTC Bureau of Consumer Protection Director ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback